Paris, France

Martine Artiaga

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sanofi. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martine Artiaga. Retrieved from https://idiyas.com/inventor/martine-artiaga

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Martine Artiaga: Innovator in Pharmaceutical Chemistry

Introduction

Martine Artiaga is a prominent inventor based in Paris, France. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative research and development of new compounds.

Latest Patents

Martine Artiaga holds a patent for "1,3,5-triazine-2-amine derivatives, preparation thereof and diagnostic and therapeutic use thereof." This invention relates to compounds that include various substituted phenyl groups and heteroaromatic groups. The patent outlines a preparation process and the diagnostic and therapeutic applications of these compounds, which can be utilized in various medical treatments.

Career Highlights

Martine is currently employed at Sanofi, a leading global healthcare company. Her work at Sanofi has allowed her to focus on developing innovative solutions in the pharmaceutical industry. With her expertise, she has contributed to advancing medical science and improving patient care.

Collaborations

Throughout her career, Martine has collaborated with notable colleagues, including Joelle Arnaud and Francis Barth. These partnerships have fostered a collaborative environment that enhances research and development efforts.

Conclusion

Martine Artiaga is a trailblazer in the field of pharmaceutical chemistry, with a focus on innovative compounds that have significant therapeutic potential. Her contributions continue to impact the healthcare industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…